vimarsana.com

Latest Breaking News On - Management board member - Page 1 : vimarsana.com

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

JJP Biologics Launches First Human Trial of Anti-Inflammatory MAb JJP-1212

JJP Biologics Launches First Human Trial of Anti-Inflammatory MAb JJP-1212
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

JJP Biologics Announces Positive Decision to Execute a FirstinHuman Clinical Trial of AntiInflammatory mAb JJP1212 antiCD89

JJP Biologics a private biopharmaceutical company developing innovative antibodybased therapies announces a positive decision issued by the European Medicines Agency on the Clinical Trial Application to conduct a phase I clinical study in healthy participants EudraCT 20235086613300 with their potential firstinclass antiCD89 antagonist JJP1212.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.